Skip to main content
Top
Published in: Digestive Diseases and Sciences 6/2020

01-06-2020 | Acute Pancreatitis | Concise Commentary

Concise Commentary: Armchair Science Redux—How Advanced In Silico Analysis Revealed Novel Insights into the Pathogenesis of Acute Pancreatitis

Authors: Calen A. Steiner, Shrinivas Bishu

Published in: Digestive Diseases and Sciences | Issue 6/2020

Login to get access

Excerpt

As the technology available to sequence genetic material becomes increasingly refined and affordable, so too does the opportunity to apply it to the diagnosis and prognosis of human disease. Modern genetic sequencing methods, including RNA sequencing, chromatin immunoprecipitation sequencing, and single-cell sequencing now offer deep views of the genetic state of organisms. This rapid technological expansion has produced an abundance of data, which when combined with modern computing power and statistical techniques have given rise to modern bioinformatics. These advances offer the enticing possibility of advancing understanding of human health and disease, including identifying novel diagnostic, prognostic, and treatment pathways, but are not without their challenges, such as analysis of these enormous data sets so as to make them useful to medicine. …
Metadata
Title
Concise Commentary: Armchair Science Redux—How Advanced In Silico Analysis Revealed Novel Insights into the Pathogenesis of Acute Pancreatitis
Authors
Calen A. Steiner
Shrinivas Bishu
Publication date
01-06-2020
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 6/2020
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-020-06085-w

Other articles of this Issue 6/2020

Digestive Diseases and Sciences 6/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine